Jack McGuire, Research Associate, joined Casdin Capital in 2022 and focuses on targeted and next-generation therapeutics.
Prior to joining Casdin, Jack worked as a strategy consultant at Back Bay Life Science Advisors, helping small-to-mid sized biotech companies navigate complex business, scientific, and financial challenges. Previously, Jack conducted cell and developmental biology research at Vanderbilt Medical Center.
Jack graduated from Vanderbilt University with a Bachelor of Science degree in Biochemistry and Chemical Biology.